Paxman AB (publ) (STO:PAX)
Sweden · Delayed Price · Currency is SEK 58.00
+0.10 (0.17%)
Sep 4, 2026, 5:24 PM CET
Paxman AB Market Cap
Paxman AB has a market cap or net worth of 1.35 billion as of September 4, 2026. Its market cap has decreased by -24.28% in one year.
Market Cap
1.35B
Enterprise Value
1.26B
Revenue
365.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.00
ChartMarket Cap Chart
Since June 12, 2017, Paxman AB's market cap has increased from 174.54M to 1.35B, an increase of 673.40%. That is a compound annual growth rate of 24.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.35B | 3.20% |
| Dec 30, 2025 | 1.31B | 4.87% |
| Dec 30, 2024 | 1.25B | 78.26% |
| Dec 29, 2023 | 699.66M | -14.62% |
| Dec 30, 2022 | 819.44M | -33.69% |
| Dec 30, 2021 | 1.24B | 203.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 3.93B |
| BICO Group AB | 1.57B |
| C-Rad AB | 1.19B |
| Sedana Medical AB | 1.10B |
| Devyser Diagnostics AB | 988.05M |
| Episurf Medical AB | 823.01M |
| Bactiguard Holding AB | 595.75M |
| Senzime AB | 553.40M |